ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Drug Discovery Outsourcing Market 2021-2025: Prioritization of Core Competencies and Increased Number of FDA-approved Manufacturing Facilities - ResearchAndMarkets.com

September 15, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Sep 15, 2021--

The “Global Drug Discovery Outsourcing Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The drug discovery outsourcing market is poised to grow by $1.42 bn during 2021-2025, progressing at a CAGR of 7.29%

The market is driven by the prioritization of core competencies and increased number of FDA-approved manufacturing facilities in developing nations.

The report on the drug discovery outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The drug discovery outsourcing market analysis includes the product segment and geographic landscape.

ADVERTISEMENT

This study identifies the short product launch timelines as one of the prime reasons driving the drug discovery outsourcing market growth during the next few years.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug discovery outsourcing market vendors that include Albany Molecular Research Inc., Aragen Life Sciences Pvt. Ltd., Charles River Laboratories International Inc., Domainex, Eurofins Scientific SE, Evotec SE, GenScript Biotech Corp., Laboratory Corp. of America Holdings, QIAGEN NV, and Thermo Fisher Scientific Inc.

Also, the drug discovery outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

ADVERTISEMENT

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Biologics - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Albany Molecular Research Inc.
  • Aragen Life Sciences Pvt. Ltd.
  • Charles River Laboratories International Inc.
  • Domainex
  • Eurofins Scientific SE
  • Evotec SE
  • GenScript Biotech Corp.
  • Laboratory Corp. of America Holdings
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/b450bv

View source version on businesswire.com:https://www.businesswire.com/news/home/20210915005910/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 09/15/2021 12:37 PM/DISC: 09/15/2021 12:37 PM

http://www.businesswire.com/news/home/20210915005910/en